Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

A P5 Approach to m-Health: Design Suggestions for Advanced Mobile Health Technology.

Gorini A, Mazzocco K, Triberti S, Sebri V, Savioni L, Pravettoni G.

Front Psychol. 2018 Oct 31;9:2066. doi: 10.3389/fpsyg.2018.02066. eCollection 2018.

2.

E-Cigarettes May Support Smokers With High Smoking-Related Risk Awareness to Stop Smoking in the Short Run: Preliminary Results by Randomized Controlled Trial.

Masiero M, Lucchiari C, Mazzocco K, Veronesi G, Maisonneuve P, Jemos C, Salè EO, Spina S, Bertolotti R, Pravettoni G.

Nicotine Tob Res. 2018 Sep 19. doi: 10.1093/ntr/nty175. [Epub ahead of print] No abstract available.

PMID:
30239904
3.

Somatic mutations in specific and connected subpathways are associated with short neuroblastoma patients' survival and indicate proteins targetable at onset of disease.

Esposito MR, Binatti A, Pantile M, Coppe A, Mazzocco K, Longo L, Capasso M, Lasorsa VA, Luksch R, Bortoluzzi S, Tonini GP.

Int J Cancer. 2018 Nov 15;143(10):2525-2536. doi: 10.1002/ijc.31748. Epub 2018 Sep 17.

PMID:
29992558
4.

Hereditary lobular breast cancer with an emphasis on E-cadherin genetic defect.

Corso G, Figueiredo J, La Vecchia C, Veronesi P, Pravettoni G, Macis D, Karam R, Lo Gullo R, Provenzano E, Toesca A, Mazzocco K, Carneiro F, Seruca R, Melo S, Schmitt F, Roviello F, De Scalzi AM, Intra M, Feroce I, De Camilli E, Villardita MG, Trentin C, De Lorenzi F, Bonanni B, Galimberti V.

J Med Genet. 2018 Jul;55(7):431-441. doi: 10.1136/jmedgenet-2018-105337. Epub 2018 Jun 21.

PMID:
29929997
5.

Psycho-cognitive predictors of burnout in healthcare professionals working in emergency departments.

Masiero M, Cutica I, Russo S, Mazzocco K, Pravettoni G.

J Clin Nurs. 2018 Jul;27(13-14):2691-2698. doi: 10.1111/jocn.14376. Epub 2018 Jun 1.

PMID:
29856096
6.

Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study.

Berbegall AP, Bogen D, Pötschger U, Beiske K, Bown N, Combaret V, Defferrari R, Jeison M, Mazzocco K, Varesio L, Vicha A, Ash S, Castel V, Coze C, Ladenstein R, Owens C, Papadakis V, Ruud E, Amann G, Sementa AR, Navarro S, Ambros PF, Noguera R, Ambros IM.

Br J Cancer. 2018 May;118(11):1502-1512. doi: 10.1038/s41416-018-0098-6. Epub 2018 May 14.

PMID:
29755120
7.

E-cigarettes May Support Smokers With High Smoking-Related Risk Awareness to Stop Smoking in the Short Run: Preliminary Results by Randomized Controlled Trial.

Masiero M, Lucchiari C, Mazzocco K, Veronesi G, Maisonneuve P, Jemos C, Salè EO, Spina S, Bertolotti R, Pravettoni G.

Nicotine Tob Res. 2018 Apr 11. doi: 10.1093/ntr/nty047. [Epub ahead of print]

PMID:
29660034
8.

Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients.

Depuydt P, Boeva V, Hocking TD, Cannoodt R, Ambros IM, Ambros PF, Asgharzadeh S, Attiyeh EF, Combaret V, Defferrari R, Fischer M, Hero B, Hogarty MD, Irwin MS, Koster J, Kreissman S, Ladenstein R, Lapouble E, Laureys G, London WB, Mazzocco K, Nakagawara A, Noguera R, Ohira M, Park JR, Pötschger U, Theissen J, Tonini GP, Valteau-Couanet D, Varesio L, Versteeg R, Speleman F, Maris JM, Schleiermacher G, De Preter K.

J Natl Cancer Inst. 2018 Oct 1;110(10):1084-1093. doi: 10.1093/jnci/djy022.

9.

Decisions and the involvement of cancer patient survivors: a moral imperative.

Pravettoni G, Cutica I, Righetti S, Mazzocco K.

J Healthc Leadersh. 2016 Dec 7;8:121-125. doi: 10.2147/JHL.S115434. eCollection 2016.

10.

A Qualitative Investigation on Patient Empowerment in Prostate Cancer.

Renzi C, Fioretti C, Oliveri S, Mazzocco K, Zerini D, Alessandro O, Rojas DP, Jereczek-Fossa BA, Pravettoni G.

Front Psychol. 2017 Jul 26;8:1215. doi: 10.3389/fpsyg.2017.01215. eCollection 2017.

11.

Professor Umberto Veronesi: a physician, a researcher, a brilliant man.

Mazzocco K, Marzorati C, Pravettoni G.

Ecancermedicalscience. 2017 Jun 8;11:742. doi: 10.3332/ecancer.2017.742. eCollection 2017.

12.

Constitutional 3p26.3 terminal microdeletion in an adolescent with neuroblastoma.

Pezzolo A, Sementa AR, Lerone M, Morini M, Ognibene M, Defferrari R, Mazzocco K, Conte M, Gigliotti AR, Garaventa A, Pistoia V, Varesio L.

Cancer Biol Ther. 2017 May 4;18(5):285-289. doi: 10.1080/15384047.2017.1312231. Epub 2017 Apr 12.

13.

How many research nurses for how many clinical trials in an oncology setting? Definition of the Nursing Time Required by Clinical Trial-Assessment Tool (NTRCT-AT).

Milani A, Mazzocco K, Stucchi S, Magon G, Pravettoni G, Passoni C, Ciccarelli C, Tonali A, Profeta T, Saiani L.

Int J Nurs Pract. 2017 Feb;23(1). doi: 10.1111/ijn.12497. Epub 2016 Dec 7.

PMID:
27925377
14.

A web-based interactive tool to improve breast cancer patient centredness.

Gorini A, Mazzocco K, Kondylakis H, McVie G, Pravettoni G.

Ecancermedicalscience. 2016 Jul 26;10:659. doi: 10.3332/ecancer.2016.659. eCollection 2016.

15.

Promoting weight loss through diet and exercise in overweight or obese breast cancer survivors (InForma): study protocol for a randomized controlled trial.

Gnagnarella P, Dragà D, Baggi F, Simoncini MC, Sabbatini A, Mazzocco K, Bassi FD, Pravettoni G, Maisonneuve P.

Trials. 2016 Jul 28;17:363. doi: 10.1186/s13063-016-1487-x.

16.

Research studies on patients' illness experience using the Narrative Medicine approach: a systematic review.

Fioretti C, Mazzocco K, Riva S, Oliveri S, Masiero M, Pravettoni G.

BMJ Open. 2016 Jul 14;6(7):e011220. doi: 10.1136/bmjopen-2016-011220. Review.

17.

Psycho-emotional tools for better treatment adherence and therapeutic outcomes for cancer patients.

Kazantzaki E, Kondylakis H, Koumakis L, Marias K, Tsiknakis M, Fioretti C, Gorini A, Mazzocco K, Renzi C, Pravettoni G.

Stud Health Technol Inform. 2016;224:129-34.

18.

Piloting the European Unified Patient Identity Management (EUPID) Concept to Facilitate Secondary Use of Neuroblastoma Data from Clinical Trials and Biobanking.

Ebner H, Hayn D, Falgenhauer M, Nitzlnader M, Schleiermacher G, Haupt R, Erminio G, Defferrari R, Mazzocco K, Kohler J, Tonini GP, Ladenstein R, Schreier G.

Stud Health Technol Inform. 2016;223:31-8.

PMID:
27139382
19.

Incidence and Determinants of Port Occlusions in Cancer Outpatients: A Prospective Cohort Study.

Milani A, Mazzocco K, Gandini S, Pravettoni G, Libutti L, Zencovich C, Sbriglia A, Pari C, Magon G, Saiani L.

Cancer Nurs. 2017 Mar/Apr;40(2):102-107. doi: 10.1097/NCC.0000000000000357.

PMID:
26925994
20.

Understanding cognitive processes behind acceptance or refusal of phase I trials.

Pravettoni G, Mazzocco K, Gorini A, Curigliano G.

Crit Rev Oncol Hematol. 2016 Apr;100:69-73. doi: 10.1016/j.critrevonc.2016.01.023. Epub 2016 Jan 23. Review.

PMID:
26852078
21.

Rationale and protocol of CML study: cognitive and emotional impact of discontinuation of therapy in patients with chronic myeloid leukemia.

Riva S, Mazzocco K, Pravettoni G.

Tumori. 2016 Mar-Apr;102(2):217-21. doi: 10.5301/tj.5000451. Epub 2015 Dec 11.

PMID:
26689667
22.

Eliminating "ductal carcinoma in situ" and "lobular carcinoma in situ" (DCIS and LCIS) terminology in clinical breast practice: The cognitive psychology point of view.

Pravettoni G, Yoder WR, Riva S, Mazzocco K, Arnaboldi P, Galimberti V.

Breast. 2016 Feb;25:82-5. doi: 10.1016/j.breast.2015.10.011. Epub 2015 Nov 21.

PMID:
26614547
23.

Decision-Making Process Related to Participation in Phase I Clinical Trials: A Nonsystematic Review of the Existing Evidence.

Gorini A, Mazzocco K, Pravettoni G.

Public Health Genomics. 2015;18(6):359-65. doi: 10.1159/000441559. Epub 2015 Nov 4. Review.

PMID:
26529420
24.

The Paradox of Pelvic Exenteration: The Interaction of Clinical and Psychological Variables.

Arnaboldi P, Santoro L, Mazzocco K, Oliveri S, Maggioni A, Pravettoni G.

Int J Gynecol Cancer. 2015 Oct;25(8):1534-40. doi: 10.1097/IGC.0000000000000523.

PMID:
26244759
25.

Development and psychometric testing of a breast cancer patient-profiling questionnaire.

Gorini A, Mazzocco K, Gandini S, Munzone E, McVie G, Pravettoni G.

Breast Cancer (Dove Med Press). 2015 Jun 1;7:133-46. doi: 10.2147/BCTT.S80014. eCollection 2015.

26.

Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma group.

Mazzocco K, Defferrari R, Sementa AR, Garaventa A, Longo L, De Mariano M, Esposito MR, Negri F, Ircolò D, Viscardi E, Luksch R, D'Angelo P, Prete A, Castellano A, Massirio P, Erminio G, Gigliotti AR, Tonini GP, Conte M.

Pediatr Blood Cancer. 2015 Oct;62(10):1725-32. doi: 10.1002/pbc.25552. Epub 2015 Apr 29.

PMID:
25925003
27.

Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification.

Defferrari R, Mazzocco K, Ambros IM, Ambros PF, Bedwell C, Beiske K, Bénard J, Berbegall AP, Bown N, Combaret V, Couturier J, Erminio G, Gambini C, Garaventa A, Gross N, Haupt R, Kohler J, Jeison M, Lunec J, Marques B, Martinsson T, Noguera R, Parodi S, Schleiermacher G, Tweddle DA, Valent A, Van Roy N, Vicha A, Villamon E, Tonini GP.

Br J Cancer. 2015 Jan 20;112(2):290-5. doi: 10.1038/bjc.2014.557. Epub 2014 Nov 4.

28.

Neuroblastoma in the adult: the Italian experience with 21 patients.

Sorrentino S, Gigliotti AR, Sementa AR, Morsellino V, Conte M, Erminio G, Buffa P, Granata C, Mazzocco K, Garaventa A, De Bernardi B.

J Pediatr Hematol Oncol. 2014 Nov;36(8):e499-505. doi: 10.1097/MPH.0000000000000144.

PMID:
24633299
29.

Development of interactive empowerment services in support of personalised medicine.

Kondylakis H, Kazantzaki E, Koumakis L, Genitsaridi I, Marias K, Gorini A, Mazzocco K, Pravettoni G, Burke D, McVie G, Tsiknakis M.

Ecancermedicalscience. 2014 Feb 11;8:400. doi: 10.3332/ecancer.2014.400. eCollection 2014. Review.

30.

Constitutional 11q14-q22 chromosome deletion syndrome in a child with neuroblastoma MYCN single copy.

Passariello A, De Brasi D, Defferrari R, Genesio R, Tufano M, Mazzocco K, Capasso M, Migliorati R, Martinsson T, Siani P, Nitsch L, Tonini GP.

Eur J Med Genet. 2013 Nov;56(11):626-34. doi: 10.1016/j.ejmg.2013.08.005. Epub 2013 Sep 13.

PMID:
24035971
31.

Bone marrow-infiltrating human neuroblastoma cells express high levels of calprotectin and HLA-G proteins.

Morandi F, Scaruffi P, Gallo F, Stigliani S, Moretti S, Bonassi S, Gambini C, Mazzocco K, Fardin P, Haupt R, Arcamone G; Italian Cooperative Group for Neuroblastoma, Pistoia V, Tonini GP, Corrias MV.

PLoS One. 2012;7(1):e29922. doi: 10.1371/journal.pone.0029922. Epub 2012 Jan 9.

32.

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study).

Schleiermacher G, Michon J, Ribeiro A, Pierron G, Mosseri V, Rubie H, Munzer C, Bénard J, Auger N, Combaret V, Janoueix-Lerosey I, Pearson A, Tweddle DA, Bown N, Gerrard M, Wheeler K, Noguera R, Villamon E, Cañete A, Castel V, Marques B, de Lacerda A, Tonini GP, Mazzocco K, Defferrari R, de Bernardi B, di Cataldo A, van Roy N, Brichard B, Ladenstein R, Ambros I, Ambros P, Beiske K, Delattre O, Couturier J.

Br J Cancer. 2011 Dec 6;105(12):1940-8. doi: 10.1038/bjc.2011.472. Epub 2011 Nov 10.

33.

Pecunia olet: the role of incidental disgust in the ultimatum game.

Bonini N, Hadjichristidis C, Mazzocco K, Demattè ML, Zampini M, Sbarbati A, Magon S.

Emotion. 2011 Aug;11(4):965-9. doi: 10.1037/a0022820.

PMID:
21534658
34.

A multilocus technique for risk evaluation of patients with neuroblastoma.

Ambros IM, Brunner B, Aigner G, Bedwell C, Beiske K, Bénard J, Bown N, Combaret V, Couturier J, Defferrari R, Gross N, Jeison M, Lunec J, Marques B, Martinsson T, Mazzocco K, Noguera R, Schleiermacher G, Speleman F, Stallings R, Tonini GP, Tweddle DA, Valent A, Vicha A, Roy NV, Villamon E, Ziegler A, Preuner S, Drobics M, Ladenstein R, Amann G, Schuit RJ, Pötschger U, Ambros PF.

Clin Cancer Res. 2011 Feb 15;17(4):792-804. doi: 10.1158/1078-0432.CCR-10-0830.

35.

Simultaneous tumors: acute myeloid leukemia infiltrating mediastinal ganglioneuroblastoma.

Di Cataldo A, Mazzocco K, Magro G, Mirabile E, Lo Nigro L, Defferrari R, Tonini GP.

Pediatr Blood Cancer. 2011 Feb;56(2):298-300. doi: 10.1002/pbc.22807.

PMID:
20973101
36.

The effect of outcome information on health professionals' spontaneous learning.

Mazzocco K, Cherubini P.

Med Educ. 2010 Oct;44(10):962-8. doi: 10.1111/j.1365-2923.2010.03744.x.

PMID:
20880365
37.

MDM2 SNP309 genotype is associated with ferritin and LDH serum levels in children with stage 4 neuroblastoma.

Parodi S, Perfumo C, Garaventa A, Inga A, Mazzocco K, Defferrari R, Tonini GP, Fronza G, Haupt R.

Pediatr Blood Cancer. 2010 Aug;55(2):267-72. doi: 10.1002/pbc.22477.

PMID:
20232446
38.

The Integrated Oncology Program of the Italian Ministry of Health. Analytical and clinical validation of new biomarkers for early diagnosis: network, resources, methodology, quality control, and data analysis.

Paradiso A, Mangia A, Orlando C, Verderio P, Belfiglio M, Marchetti A, Bertario L, Chiappetta G, Gion M, Tonini GP, Podo F, Vocaturo A, Silvestrini R, Romani M, Belloni E, Cavallo D, Ulivi P, Tommasi S, Steffan A, Russo A, Alessio M, Calistri D, Zancan M, Parrela P, Broggini M, Giuseppe A, Buttitta F, Finocchiaro G, Mazzocco K, Veronesi G, Landuzzi L, Benevolo M, Mariani L, De Marco F, Venuti A, Giannelli G, Quaranta M, Trojano V.

Int J Biol Markers. 2009 Jul-Sep;24(3):119-29.

PMID:
19787622
39.

Outcome prediction and risk assessment by quantitative pyrosequencing methylation analysis of the SFN gene in advanced stage, high-risk, neuroblastic tumor patients.

Banelli B, Bonassi S, Casciano I, Mazzocco K, Di Vinci A, Scaruffi P, Brigati C, Allemanni G, Borzì L, Tonini GP, Romani M.

Int J Cancer. 2010 Feb 1;126(3):656-68. doi: 10.1002/ijc.24768.

40.

MDM2 SNP309 genotype influences survival of metastatic but not of localized neuroblastoma.

Perfumo C, Parodi S, Mazzocco K, Defferrari R, Inga A, Scarrà GB, Ghiorzo P, Haupt R, Tonini GP, Fronza G.

Pediatr Blood Cancer. 2009 Oct;53(4):576-83. doi: 10.1002/pbc.22132.

PMID:
19526525
41.

Impact of MDM2 SNP309 genotype on progression and survival of stage 4 neuroblastoma.

Perfumo C, Parodi S, Mazzocco K, Defferrari R, Inga A, Haupt R, Fronza G, Tonini GP.

Eur J Cancer. 2008 Nov;44(17):2634-9. doi: 10.1016/j.ejca.2008.08.018. Epub 2008 Oct 1.

PMID:
18835771
42.

Surgical team behaviors and patient outcomes.

Mazzocco K, Petitti DB, Fong KT, Bonacum D, Brookey J, Graham S, Lasky RE, Sexton JB, Thomas EJ.

Am J Surg. 2009 May;197(5):678-85. doi: 10.1016/j.amjsurg.2008.03.002. Epub 2008 Sep 11.

PMID:
18789425
43.

Risk factors for non-adherence to medication in inflammatory bowel disease patients.

D'Incà R, Bertomoro P, Mazzocco K, Vettorato MG, Rumiati R, Sturniolo GC.

Aliment Pharmacol Ther. 2008 Jan 15;27(2):166-72. Epub 2007 Oct 20.

44.

Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization.

Scaruffi P, Coco S, Cifuentes F, Albino D, Nair M, Defferrari R, Mazzocco K, Tonini GP.

Cancer Genet Cytogenet. 2007 Aug;177(1):20-9.

PMID:
17693187
45.

Concomitant DDX1 and MYCN gain in neuroblastoma.

Defferrari R, Tonini GP, Conte M, Papio F, Sementa AR, Valent A, Schena F, Perri P, Mazzocco K.

Cancer Lett. 2007 Oct 18;256(1):56-63. Epub 2007 Jul 3.

PMID:
17611020
46.

Numeracy and decision making.

Peters E, Västfjäll D, Slovic P, Mertz CK, Mazzocco K, Dickert S.

Psychol Sci. 2006 May;17(5):407-13.

PMID:
16683928
47.

Neuroblastoma in adolescents: the Italian experience.

Conte M, Parodi S, De Bernardi B, Milanaccio C, Mazzocco K, Angelini P, Viscardi E, Di Cataldo A, Luksch R, Haupt R.

Cancer. 2006 Mar 15;106(6):1409-17.

48.

Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cells.

Coco S, Defferrari R, Scaruffi P, Cavazzana A, Di Cristofano C, Longo L, Mazzocco K, Perri P, Gambini C, Moretti S, Bonassi S, Tonini GP.

J Pathol. 2005 Nov;207(3):346-57.

PMID:
16178058
49.

[The framing effect: medical implications].

Mazzocco K, Cherubini P, Rumiati R.

Ann Ital Med Int. 2005 Jan-Mar;20(1):1-9. Review. Italian.

PMID:
15859389
50.

Detection of MYCN amplification and chromosome 1p36 loss in neuroblastoma by cDNA microarray comparative genomic hybridization.

Scaruffi P, Parodi S, Mazzocco K, Defferrari R, Fontana V, Bonassi S, Tonini GP.

Mol Diagn. 2004;8(2):93-100.

PMID:
15527323

Supplemental Content

Loading ...
Support Center